Abstract
Survival, cardiac, and pulmonary outcomes in individuals with attenuated MPS I receiving laronidase enzyme replacement therapy: Data from the MPS I Registry
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have